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Abstract 
Embryonic loss is an issue that livestock producers are faced with worldwide. This 
particular research assesses one aspect of the role that immune cells play in embryonic 
survival, more specifically, the interaction between peripheral blood mononuclear cells 
and bovine endometrial cells, and their connection to interferon-stimulated genes. 
Peripheral blood mononuclear cells were taken from three different cows and were 
cultured with bovine endometrial cells. Some of the cultures contained interferon, and 
some did not. After incubation, results showed that the immune cells did not increase 
interferon-stimulated genes, and are stimulating a pathway in the response to pregnancy 
that is currently unknown.  
Background 
 
As the population of the world steadily increases, animal scientists are faced with the 
challenge of producing more animal protein to feed the world. One estimate states that by 
the year 2050, the production of food will have to increase by seventy percent 
(Alexandratos & Bruinsima, 2012). One means of addressing this issue focuses on 
increasing the reproductive efficiency of cattle in order to increase the amount of beef 
and dairy products available for consumption. Increasing fertilization rates is typically 
not the problem with cattle, however, they do suffer from a high rate of embryonic loss 
(McMillan, 1998). According to Diskin & Morris (2008), fertilization rates generally fall 
between ninety and one hundred percent for most cattle, with the exception of high-
producing dairy cows who are typically lower. Currently, research is being performed 
that is focused on addressing the issue of embryonic loss. Fair (2015) stated that the 
embryonic and fetal mortality rate in cattle is around thirty-five percent.  If this relatively 
high rate of embryonic loss can be decreased, this not only would save livestock 
producers a large sum of money, but would also enable them to utilize current 
reproductive technologies in a way that makes a more efficient impact to the food supply. 
One such reproductive technology that is widely used is embryo transfer. Embryo 
transfer is used to select desired genetics to produce valuable males and females (Ideta et 
al., 2010). This is a very useful reproductive technology, however, if embryonic loss 
continues to occur at the rate that it does, technologies such as embryo transfer are not 
reaching their full potential. 
 
Many scientists are devoting their research to addressing the issue of embryonic loss 
from an immunological perspective. The maternal immune system has been found to be 
an influential part of pregnancy from the time of insemination and throughout the entire 
pregnancy. Though the maternal immune system is not the only factor influencing 
embryonic and fetal survival, it does play a large role in making sure a healthy pregnancy 
occurs. This type of research is still continuing around the world to gain a better 
understanding of maternal immunity in hopes of addressing embryonic loss and infertility 




In both cattle and sheep, the embryo enters the uterus around days four to five following 
fertilization and becomes a blastocyst around day six or seven (Fair, 2015; Takahashi et 
al., 2016). In cattle, implantation of the embryo to the uterus does not begin to occur until 
day nineteen, therefore leaving nineteen days for the embryo to face the first effects of 
immune response and survive off of uterine secretions. These uterine secretions are 
regulated by P4 (progesterone) and are a crucial part of maintaining growth of the 
conceptus (Takahashi et al., 2016). It is believed that the events that occur during the first 
few days after mating have a large effect on whether the embryo will be lost or will 
become a viable fetus. Fair (2015) stated an estimate that “70-80% of the total embryonic 
loss occurs between days 8 and 16 after insemination.” Another study also found that 
embryonic loss in cattle generally happens before day sixteen after breeding, and in high 
producing dairy cows, there has been a large occurrence of embryonic loss before day 
eight (Diskin & Morris, 2008). At this point of development, the conceptus is faced with 
having to inhibit the secretion of PGF2α from the uterus, which is a possible explanation 
for embryonic loss if the conceptus fails to do this (Thatcher et al., 2001). Another 
possibility, however, has to do with the immune system. From the time immediately after 
insemination to the time of embryo implantation, the maternal immune system plays a 
significant role in the establishment of pregnancy by altering its function to protect the 
embryo and promote a successful pregnancy. Because of this, researchers are looking into 
the possibility that the maternal immune system is affecting the current rate of embryonic 
loss that producers are experiencing.  
 
During the course of reproduction, the immune system of the female is exposed to many 
foreign antigens including the semen itself as well as the conceptus (Seamark et al., 
1992). Typically, foreign antigenic material is attacked by immune cells so the body can 
rid itself of the foreign material. Pregnancy, therefore, is an “immunological 
contradiction” because the foreign material that is introduced into the female 
reproductive tract is not rejected but rather forms a close relationship with the uterus 
(Walker et al., 2010). It is clear that the immune systems of humans and animals have 
special adaptations when it comes to pregnancy so that the foreign embryo can bypass 
immune system attack and avoid being rejected from the mother’s body. This includes 
suppressing cytotoxic adaptive immunity, increasing regulatory adaptive immunity, and 
maintaining innate immunity. If this type of immune system alteration were not in place, 
successful pregnancy would not occur. In every stage of the reproductive cycle, immune 
cells are present (Seamark et al., 1992). When a pregnancy is detected, it becomes a 
matter of balancing both pro-inflammatory and anti-inflammatory molecules in order to 
maintain an optimal environment for the developing embryo (Walker et al., 2010).  
 
In women and cattle, it has been found through research that transferring autologous 
immune cells to the uterus increases pregnancy rates (Chase et al., 2015). Peripheral 
blood mononuclear cells (PBMCs) have the capability to secrete proteases, which likely 
plays a role in uterine regulation (Yoshioka et al, 2006). Through the research of Ideta et 
al. (2010), an increased pregnancy rate was found for cows administered PBMCs into the 
uterus prior to pregnancy compared to those who were not administered them. 
Additionally, Yoshioka et al., (2006) performed an experiment where PBMCs were taken 
from women and cultured with human chorionic gonadotropin and administered into the 
uterus along with fresh PBMCs three days before embryo transfer was performed. They 
found that this was a successful way to increase implantation and overall pregnancy rates 
likely due to the activation of the PBMCs when exposed to stromal tissue (Yoshioka et 
al., 2006). Collectively, these results illustrated that the peripheral blood mononuclear 
cells initiated a response in the endometrium that conditioned it for pregnancy which 
leads into the next topic, immunological priming (Ideta et al., 2010). 
 
Immunological Priming  
 
Now aware of the changes that occur to the maternal immune system, researchers are 
looking into what actually causes this change in immune function. This leads to the topic 
of immunological priming. Immunological priming is essentially when immune cells first 
come in contact with a foreign antigen, promoting the immune cells to differentiate into 
effector B or T cells. These effector cells can be in the form of cytotoxic T cells, 
cytokines or antibodies and are produced depending on the task that the immune system 
faces. It is believed that certain components of semen, including the foreign antigens that 
it contains, play a role in priming the immune cells of the mother in order to facilitate a 
successful pregnancy (Robertson, 2005). Recent studies on livestock, rodents and humans 
have shown that the mere exposure of the female to seminal fluid during coitus induces 
certain changes in the female that promotes conception and successful pregnancy. In 
mice it has been found that as soon as semen deposition occurs, inflammatory cells 
immediately travel to the site to initiate a post-mating inflammatory response (Robertson, 
2005). In another study, it was reported that neutrophils were released into the uterine 
lumen within an hour after mating, followed by other types of immune cells (Schjenken 
& Robertson, 2014). The reason why this inflammatory response occurs so quickly after 
mating is clearly understood. The central role of this inflammatory response is to clear 
excess sperm from the uterus and try to regain the sterility of the reproductive tract after 
it was exposed to foreign material containing potentially harmful microorganisms 
(Schjenken & Robertson, 2014). Following this, immune changes continue to occur to 
prepare the uterus for pregnancy. When seminal fluid contacts epithelial cells in the 
female reproductive tract, certain molecules in the fluid bind to receptors to initiate 
changes in gene expression (Robertson, 2005). This upregulation of certain genes is 
thought to be a key component of embryonic immune tolerance (Walker et al., 2010). 
Tissue remodeling of the uterus to increase embryonic receptivity as well as activation of 
the maternal immune response due to seminal antigen exposure occur as a result of this 
inflammatory response that is initiated by seminal fluid (Robertson, 2005).  
 
For years, it has been general knowledge that the sperm component of semen is important 
for reproduction, but more recently it has been found that the portion of the semen that 
does not contain sperm, seminal plasma, also plays an important role in the reproductive 
process (Robertson, 2005). Seminal plasma contains cytokines, sex hormones and 
prostaglandins that are all crucial in the reproductive process (Schjenken & Robertson, 
2014). This claim is supported by a study that analyzes reproduction in mice. It was 
found that the success of embryo transfer was directly correlated with if the recipient was 
mated with a vasectomized male (Robertson, 2005). By mating with the vasectomized 
rat, the female was still being exposed to the seminal plasma portion of the ejaculate, 
which showed to help decrease the occurrence of embryonic loss and fetal abnormalities 
(Robertson, 2005). Bromfield et al. (2004) also uncovered supporting evidence when 
recipient females were mated with males who lacked a functional seminal vesicle and 
fetuses with growth rate abnormalities as well as placental abnormalities were found. The 
research performed by Bellinge et al., (1986) showed that this is also the same case with 
humans when an increase in live birth rates was observed in women who had sexual 
intercourse near the time that they underwent in vitro fertilization. In addition, Seamark 
et al. (1992) also found that a component of semen enhances fertility in the pig after 
intrauterine insemination. In all of these cases, it was found that the seminal plasma 
component of seminal fluid stimulated the tissues of the female reproductive tract to 
promote the establishment of a successful pregnancy.  
 
Immune Cells Involved in Seminal Priming 
 
As described above, when the maternal immune system is exposed to the antigens and 
other factors that are in seminal fluid, a certain activation of the immune system occurs. 
Seminal activation essentially generates an immune tolerance to the foreign antigens to 
avoid the lymphocytes that respond to cause cytotoxic damage to the embryo or the 
sperm (Robertson et al., 2009). According to Schjenken and Robertson (2014), the 
foreign conceptus expresses a variety of antigens, one type “encoded by major 
histocompatibility genes derived from paternal chromosomes”. Because the female 
immune system has no recognition of these antigens, an immune activation response 
initiates. This activation process begins when endometrial stromal tissue is exposed to the 
foreign antigens present in seminal fluid, and macrophages and dendritic cells are 
brought to the site of exposure (Robertson, 2005). In short, macrophages and dendritic 
cells are both leukocytes that function as antigen presenting cells, and in this case, they 
present foreign seminal antigens to helper T cells in the uterine draining lymph nodes to 
continue the activation of subsequent immune responses (Robertson, 2005). Despite 
different species having different sites of semen deposition, evidence of seminal fluid 
signaling has been found in pigs, horses, cattle, sheep, and dogs (Schjenken & Robertson, 
2014).  
 
This process of seminal activation results in the production of several different types of 
immune cells that aid in successful pregnancy. Cytokines are one of these types of 
immune cells, and they are responsible for organizing cell-to-cell activity via cellular 
signaling (Robertson, 2005). Once the production of cytokines has been induced by 
seminal exposure, they are secreted into the fluid of the uterus to target the cytokine 
receptors on the embryo. Once this activity begins in the uterus, these cytokines express 
their embryotrophic properties by organizing a nourishing environment in the oviduct and 
uterus for the embryo to avoid embryonic loss (Robertson, 2005). One important 
cytokine, in particular, is transforming growth factor β (TGFβ). Fair (2015) stated that the 
TGFβ found in seminal plasma is the primary trigger for the inflammatory response that 
occurs at semen exposure. While inside the male it is thought to be in a latent form, 
which makes the transition to an active form by enzymes such as plasmin to induce a 
leucocytic response in the female reproductive tract (Fair, 2015; Schjenken & Robertson, 
2014). According to Schjenken and Robertson (2014), both paternal antigens and 
cytokines play key roles in the signaling events that result in immunological tolerance of 
the conceptus.  
 
Seminal activation also contributes to the production of regulatory T cells. Regulatory T 
cells, otherwise known as Treg cells, function to suppress cytokine production as well as 
effector function of B and T cells, dendritic cells, macrophages and natural killer cells in 
order to avoid the harmful effects of destructive immunity (Robertson et al., 2009; 
Schjenken & Robertson, 2014). Treg cells are found throughout the body, including the 
gut where inflammation exacerbates any problems already present. In this case,Treg cells 
are found in the uterus and play a large role in the success of a pregnancy. These 
specialized cells must be activated in order to suppress inflammation and protect the fetus 
from being subjected to a harsh immune response. Both the developing conceptus and 
sperm express antigens that would typically be recognized by the immune system as 
foreign and could induce an inflammatory immune response that could terminate the 
pregnancy. Instead, under normal circumstances, peripheral tissues are induced to 
produce Treg cells when reproductive antigens are detected (Robertson et al., 2009). The 
job of the Treg cells is to recognize that these cells are indeed foreign, but are not harmful 
and do not need to be acted against, which is a job that no other cell has the specific 
capacity to do. This idea is known as is known as Treg cell-mediated immune tolerance, 
or in this case, maternal tolerance. In mice, if the mother is deficient of Treg cells, the 
allogenic fetus will be rejected (Aluvihare et al., 2009).  
 
In Robertson’s lecture (2015), she discussed the main factors that were important in 
establishing a sufficient Treg cell population. In addition to the proper phenotype of 
dendritic cells and endometrial macrophages, a balance of cytokines, and proper estrogen 
and progesterone levels, it is also important that the seminal fluid that the female is 
exposed to contains MHC antigens and immune suppression agents (Robertson, 2015). 
According to Leung et al. (2000), the precise mechanism to which maternal tolerance 
occurs is not thoroughly understood, however it is likely that these MHC antigens are 
changed and immunomodulatory signals are produced in order to establish maternal 
tolerance. The research of Schjenken and Robertson (2014) supports this claim, stating 
that it is likely genetic mismatch of MHC antigens that stimulated an increase in the Treg 
cell population. 
 
When observing the lymph nodes that are responsible for draining the uterus, Aluvihare 
et al., (2004) reported that the number of Treg cells had already increased two days after 
mating. Additionally, if the Treg cell level is depleted two days after mating or Treg cells 
do not function properly, implantation failure is likely to occur (Zenclussen et al., 2005). 
This illustrates the importance for Treg cells prior to implantation. It is thought that the 
exposure of Treg cells to seminal plasma during mating is an important step in activating 
the Treg cells to protect the growing fetus in the future by maintaining an 
immunologically suppressed uterine environment (Robertson et al., 2009). There are two 
times when the Treg cells are exposed to paternal alloantigen during reproduction. The 
first is when the female is exposed to seminal fluid during mating, and the last is during 
the process of embryo implantation (Robertson et al., 2009). It is known that Treg cells 
play a large role in the embryo implantation process, therefore Robertson et al. (2009) 
hypothesized that the male alloantigens that are in seminal fluid might contribute to the 
priming of regulatory T cells prior to implantation. Through the research of Robertson et 
al., (2009) it was found that the plasma component of the semen as well as the sperm are 
necessary to activate the T cells in the lymph nodes in contact with the uterus maternal 
tolerance. The general mechanism of activation of Treg cells in the uterine lymph node is 
as follows. First, the exposure of the female to seminal fluid promotes recruitment and 
maturation of tolerogenic dendritic cells that function to phagocytose sperm and male 
somatic cells and bring them to the draining uterine lymph nodes (Robertson et al., 2009). 
Then, the sperm and male somatic cells interact with Treg cells in the uterine tissue, 
which activates Treg cells that express T cell receptors that react with antigens in seminal 
fluid (Robertson et al., 2009). The activation of Treg cells induces proliferation of cell 
numbers, which explains why the Treg cell numbers rise as early as two days after mating 
in mice.  
 
In addition to the immune cell types discussed, there are countless other factors that 
contribute to reproductive success, reinstating why a delicate balance is so important 
during pregnancy.  Not only do components of the seminal plasma stimulate a leucocytic 
response themselves, but they also associate with the endometrium to produce additional 
molecules that contribute to the overall immune response. Bacterial lipopolysaccharide, 
Toll-like receptors and many other factors that were not discussed play a role in 
establishing a uterine environment that is optimal for a healthy pregnancy (Schjenken & 
Robertson, 2014). 
 
Analysis of Thesis Research 
 
This particular study was performed by first collecting peripheral blood mononuclear 
cells from three different cows. The peripheral blood mononuclear cells were split into 
two cultures, with one culture containing IFN and one culture not containing IFN. After 
24 hours, the peripheral blood mononuclear cells were added to immortalized bovine 
endometrial cells and cultured for 24 hours. The bEND cell line was used, which simply 
means that the cells were from endometrial tissue of female cows. The control of the 
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Figure 1: Fold change values of the control sample (bEND cells), interferon 
sample, peripheral blood mononuclear cell (PBMC) sample, and the combined 
PBMC and interferon sample.  
 
 
Figure 2: The fold change samples in the Figure 1 chart were put on a bar graph to 
illustrate the drastic fold increase in the fold change of IFN, showing that IFN is 































Figure 3: This visual representation shows that when bovine endometrial cells are 
exposed to peripheral blood mononuclear cells, a pathway that is separate from the 




The particular gene of focus in this research was MX1, an interferon-stimulated gene that 
is stimulated by Type I and Type III IFN to induce an antiviral response. As previously 
discussed, these types of responses are crucial for a healthy pregnancy by protecting the 
fetus from infection. The results of the research of Ideta et al. (2006) indicated that 
peripheral blood mononuclear cells stimulated a response in the endometrial tissue, and 
the results of this research narrowed the response down by verifying that PBMCs 
stimulate a non-interferon pathway in the bovine endometrial cells. This was indicated in 
both Figures 1 and 2. The fold change of the bEND cells themselves (control) was 1.4 in 
comparison to the interferon stimulated gene (ISG) MX1, showing that the endometrial 
cells do not stimulate ISGs themselves. The fold change of interferon and bEND cells 
was 212 in comparison to MX1, which was expected because MX1 is an interferon-
stimulated gene. The fold change of PBMCs and bEND cells was 1.2 in comparison to 
MX1 showing that there was almost no increase in expression of MX1 when PBMCs and 
bEND cells were co-cultured together. The fold change of the co-culture of PBMCS, IFN 
and bEND cells in comparison to MX1 was 1.3 which showed that there was almost no 
increase in expression of MX1 in this case either. With these values, it was concluded 
that the PBMCs stimulated a non-interferon pathway in the bovine endometrial cells. A 
fold change value of ~1 indicates that there was no change in gene expression. In order to 
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conclude that the PBMCs were, in fact, stimulating an interferon pathway in the bEND 
cells, the fold change should be much higher than 1.3, like in the case of the IFN culture. 
From this, we can conclude that when bovine endometrial cells were exposed to PBMCs, 
the PBMCs did not act as IFN tau, and a pathway that is currently unknown was 
stimulated in order to promote successful pregnancy. 
 
Recently, Chase et al. (2015), found that when they primed peripheral blood mononuclear 
cells with Interferon tau and transferred them into the uterus, pregnancy rates were 
increased. In order for the embryo to survive in the uterus, it must begin to secrete IFN 
tau in order to inhibit luteolysis. This particular research showed that the immune cells 
are not necessarily associated with IFN tau. The conclusion that formed was that IFN tau 
interacts with the embryo, and immune cells are doing something else at the same time.  
 
Future research is required to identify the pathway that the immune cells (PBMCs) 
stimulate in the bovine endometrium. When this pathway is discovered, further 
assessment has the potential to identify a role that this pathway plays in the rate of 
embryonic survival. As discussed earlier, seminal priming of immune cells has been 
found to play a role in the rate of embryonic survival and implantation. Therefore, it 
would be beneficial for future researchers to look at the role that immunological priming 
of the PBMCs plays in the success of this unknown pathway in the bovine endometrial 
cells that is stimulated by the PBMCs. Further research into this unknown pathway, as 
well as reproductive immunology as a whole, has potential to help producers increase 
pregnancy rates in their cattle by allowing them to both understand and address 
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